US$ 22.51
sulfonylurea vs glp 1 Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records What classes of diabetes medications
Description
Clinical Pharmacology and Therapeutics
2019 Oct;7(4):575586
Systemic and endothelial inflammation contribute to collagen deposition, interstitial fibrosis and therefore atrial and ventricular remodelling as well as vascular stiffening [9, 10]

[DOI] [PubMed] [Google Scholar] 444.Wang, D
